🇺🇸 FDA
Patent

US 10201591

TSLP induces neutrophil mediated killing of methicillin-resistant staphylococcus aureus

granted A61KA61K38/19A61K9/0014

Quick answer

US patent 10201591 (TSLP induces neutrophil mediated killing of methicillin-resistant staphylococcus aureus) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/19, A61K9/0014, A61K9/0019